EGFR and benign prostatic hyperplasia: Previous in vivo and in vitro studies by our group showed that QC exhibited activity against BPH via the promotion of apoptosis, suppression of the EGFR/STAT3 signaling pathway and regulating the expression of sex hormones as well as their receptors (21–24).